In the News

May 16, 2017

As national Republican leaders continue to try to defund Planned Parenthood, California and other states are considering steps to protect access to family planning services.

May 11, 2017

By Michelle Faust

Gov. Jerry Brown’s revised budget plan released Thursday does not restore $33 million for medical residencies in areas facing significant doctor shortages, disappointing state lawmakers and doctors' groups. 

May 4, 2017

Many of the 5 million Californians who receive health coverage through the Affordable Care Act risk losing insurance under a GOP health care bill passed by the House of Representatives Thursday. State and health industry officials said they hoped the U.S. Senate would block the bill or revise it to better protect low-income communities and people with pre-existing conditions.

May 1, 2017

In an attempt to shield the state from federal policy changes, California legislators are working on a series of women’s health bills.

A bill introduced by Sen. Ed Hernandez of West Covina would require the state’s low-income health plan to continue ensuring access to reproductive health care even if the federal government changes its coverage.

April 24, 2017

Pharmaceutical companies need an intervention to address their addiction to prescription drug price gouging. Californians should demand that Big Pharma be more transparent about drug pricing habits and put an end to industry practices that state Sen. Ed Hernandez says benefit drugmakers at the expense of taxpayers.

April 18, 2017

By Ed Hernandez and Tom Steyer

Big Pharma is everywhere.

Ads for the latest and greatest “lifestyle” drugs clog our magazines and spill out of our TVs. Every ailment is now a disease with a name and a medication to match.

The truth is, we can’t avoid Big Pharma because it’s the only game in town. Thanks to government-authorized monopoly protections, we have no choice but to pay whatever price Big Pharma charges, no matter how high.

March 20, 2017


Una nueva propuesta de ley en California busca que las empresas farmacéuticas notifiquen a consumidores antes de elevar los precios de sus medicamentos.

La medida SB 17 también requeriría que los planes de salud reporten la proporción de lo que gastan en el costo de medicinas recetadas.